Management of Infants Born to Mothers with Positive VDRL
Initial Evaluation of the Newborn
- Perform a complete physical examination looking for signs of congenital syphilis (hepatosplenomegaly, skin lesions, rhinitis, jaundice, anemia) as recommended by the CDC MMWR Recommendations. 1
- Obtain a quantitative VDRL on the infant and compare the titer with the maternal titer (CDC MMWR Recommendations). 1, 2
- Review the maternal history in detail—including timing of treatment, regimen used, serologic response, and any possibility of reinfection (CDC MMWR Recommendations). 1, 2
Scenario 1 – Mother Untreated, Inadequately Treated, or Treated with Non‑Penicillin
Mandatory complete work‑up:
First‑line treatment – Aqueous crystalline penicillin G 100,000–150,000 U/kg/day IV (50,000 U/kg every 12 h for the first 7 days, then every 8 h) for a total of 10 days (CDC MMWR Recommendations). 1, 3, 2
Alternative regimens –
Critical warning – If a single‑dose benzathine regimen is used and any abnormality is later identified (or any test is missing/CSF contaminated), the infant must receive the full 10‑day IV penicillin course (CDC MMWR Recommendations). 1, 3
Scenario 2 – Mother Treated Adequately During Pregnancy
Applicable when the mother received appropriate penicillin therapy > 4 weeks before delivery, with no evidence of reinfection, and the infant has:
- Normal physical examination (CDC MMWR Recommendations).
- Infant VDRL ≤ 4 × maternal titer (CDC MMWR Recommendations).
Recommended treatment – Single‑dose benzathine penicillin G 50,000 U/kg IM (CDC MMWR Recommendations). 1, 4
Acceptable alternative – If maternal non‑treponemal titers fell ≥ 4‑fold after appropriate treatment for early syphilis (or remained low/stable for late syphilis), close serologic follow‑up without infant treatment may be considered (CDC MMWR Recommendations). 1, 4
Scenario 3 – Mother Treated Adequately Before Pregnancy
When the mother was treated before conception and maternal non‑treponemal titers remained low/stable (VDRL < 1:2, RPR < 1:4), and the infant has:
- Normal physical examination (CDC MMWR Recommendations).
- Infant VDRL ≤ 4 × maternal titer (CDC MMWR Recommendations).
Recommended management – No antibiotic treatment required (CDC MMWR Recommendations). 5, 2
Optional – A single dose of benzathine penicillin G 50,000 U/kg IM may be given if reliable follow‑up is uncertain (CDC MMWR Recommendations). 5, 2
Interpretation of Infant VDRL Titers
- An infant VDRL > 4 × the maternal titer indicates active congenital infection and mandates full evaluation and treatment (CDC MMWR Recommendations). 1, 2
- Maternal IgG antibodies can be passively transferred and may persist in the infant up to 15 months of age (CDC MMWR Recommendations). 1, 5
- A reactive non‑treponemal test at 18 months of age signifies congenital syphilis and requires re‑evaluation and complete treatment (CDC MMWR Recommendations). 1, 5
Serologic Follow‑up
- For all infants (treated or untreated), obtain quantitative VDRL at 3, 6, and 12 months of age (CDC MMWR Recommendations). 1, 5
If titers remain stable or increase, this suggests active infection and requires full evaluation and treatment (CDC MMWR Recommendations). 1, 5
For infants with an abnormal CSF result initially:
Common Pitfalls to Avoid
- Do not assume maternal treatment was adequate without confirming the specific regimen, timing, and serologic response (CDC MMWR Recommendations). 2
- Do not rely solely on a single‑dose benzathine penicillin when the mother was untreated or inadequately treated without completing the full infant evaluation (CDC MMWR Recommendations). 3, 2
- Do not use treponemal tests (e.g., FTA‑ABS) for infant follow‑up, as they remain positive despite effective therapy (CDC MMWR Recommendations). 1, 5